19 results on '"Yamatsu Y"'
Search Results
2. Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection
- Author
-
Yamaguchi, T., primary, Makiguchi, T., additional, Nakamura, H., additional, Yamatsu, Y., additional, Hirai, Y., additional, Shoda, K., additional, Suzuki, K., additional, Kim, M., additional, Kurozumi, S., additional, Motegi, S.I., additional, Shirabe, K., additional, and Yokoo, S., additional
- Published
- 2021
- Full Text
- View/download PDF
3. Two-color infrared FEL facility at the Saga synchrotron light source in 2003
- Author
-
Tomimasu, T., primary, Koda, S., additional, Iwasakf, Y., additional, Yasumoto, M., additional, Kitsuka, T., additional, Yamatsu, Y., additional, Mitsutake, T., additional, Mori, M., additional, and Ochiai, Y., additional
- Published
- 2004
- Full Text
- View/download PDF
4. Two-color infrared FEL facility at the Saga synchrotron light source in 2003
- Author
-
Tomimasu, T, Koda, S, Iwasaki, Y, Yasumoto, M, Kitsuka, T, Yamatsu, Y, Mitsutake, T, Mori, M, and Ochiai, Y
- Published
- 2004
- Full Text
- View/download PDF
5. Two-color IR-FEL facility for semiconductor and bio-medical applications at Saga synchrotron light source
- Author
-
Yasumoto, M., primary, Tomimasu, T., additional, Iwasaki, Y., additional, Yamatsu, Y., additional, Koga, N., additional, Hashiguchi, Y., additional, Ochiai, Y., additional, Yamada, K., additional, Sei, N., additional, and Ogawa, H., additional
- Published
- 2002
- Full Text
- View/download PDF
6. Lattice design of Saga synchrotron light source.
- Author
-
Iwasaki, Y., Koda, S., Tomimasu, T., Ohgaki, H., Toyokawa, H., Yasumoto, M., Yamatsu, Y., Kitsuka, T., Hashiguchi, Y., and Ochiai, Y.
- Published
- 2003
- Full Text
- View/download PDF
7. The Saga synchrotron light source in 2003.
- Author
-
Tomimasu, T., Koda, S., Iwasaki, Y., Ohgaki, H., Toyokawa, H., Yasumoto, M., Yamatsu, Y., Kitsuka, T., Hashiguchi, Y., and Ochiai, Y.
- Published
- 2003
- Full Text
- View/download PDF
8. Peptide-to-Small Molecule: Discovery of Non-Covalent, Active-Site Inhibitors of β-Herpesvirus Proteases.
- Author
-
Yoshida S, Sako Y, Nikaido E, Ueda T, Kozono I, Ichihashi Y, Nakahashi A, Onishi M, Yamatsu Y, Kato T, Nishikawa J, and Tachibana Y
- Abstract
Viral proteases, the key enzymes that regulate viral replication and assembly, are promising targets for antiviral drug discovery. Herpesvirus proteases are enzymes with no crystallographically confirmed noncovalent active-site binders, owing to their shallow and polar substrate-binding pockets. Here, we applied our previously reported "Peptide-to-Small Molecule" strategy to generate novel inhibitors of β-herpesvirus proteases. Rapid selection with a display technology was used to identify macrocyclic peptide 1 bound to the active site of human cytomegalovirus protease (HCMV
Pro ) with high affinity, and pharmacophore queries were defined based on the results of subsequent intermolecular interaction analyses. Membrane-permeable small molecule 19 , designed de novo according to this hypothesis, exhibited enzyme inhibitory activity (IC50 = 10-6 to 10-7 M) against β-herpesvirus proteases, and the design concept was proved by X-ray cocrystal analysis., Competing Interests: The authors declare the following competing financial interest(s): S.Y., Y.S., E.N., T.U., I.K., Y.I., A.N., M.O., Y.Y., T.K., and Y.T. are employees of SHIONOGI & Co., Ltd. J.N. is an employee of PeptiDream Inc. S.Y., E.N., T.U., Y.I., and T.K. are shareholders in SHIONOGI & Co., Ltd. J.N. is a shareholder of PeptiDream Inc., (© 2023 American Chemical Society.)- Published
- 2023
- Full Text
- View/download PDF
9. [Compartment Syndrome After Stanford Type A Acute Aortic Dissection Surgery:Report of a Case].
- Author
-
Kaga T, Ezure M, Hasegawa Y, Yamada Y, Hoshino J, Okada S, Morishita H, Seki M, Konno N, Oi A, Tamura N, Atomura D, and Yamatsu Y
- Subjects
- Humans, Male, Middle Aged, Leg, Cardiopulmonary Bypass, Femoral Artery diagnostic imaging, Femoral Artery surgery, Compartment Syndromes diagnostic imaging, Compartment Syndromes etiology, Compartment Syndromes surgery, Aortic Dissection diagnostic imaging, Aortic Dissection surgery
- Abstract
A 53-year-old man presented to the emergency department with chest and back pain. Contrast-enhanced computed tomography( CT) revealed a Stanford type A acute aortic dissection with a pseudo-lumen occlusion. On the same day, the patient underwent emergent aortic arch replacement with frozen elephant trunk. When introducing cardiopulmonary bypass, arterial cannula was inserted into the right femoral artery. The day after surgery, swelling of the right lower leg appeared with CK and intramuscular compartment pressure elevation. Thus, the patient was diagnosed with compartment syndrome and decompressive fasciotomy was performed. Although there was no preoperative blood flow disturbance in the lower extremities on preoperative CT, lower limbs ischemia happened. Necrotic muscles in his right leg required debridement, but amputation was not needed. The patient was discharged unaided utilising orthotics on the day 120. In muscular, young male patients, care should be taken in the method of blood delivery.
- Published
- 2023
10. Staphylococcal Toxic Shock Syndrome after Autologous Breast Reconstruction: A Case Report and Literature Review.
- Author
-
Nakamura H, Makiguchi T, Hasegawa Y, Yamatsu Y, Shoda K, Mori Y, Sakurai K, Shirabe K, and Yokoo S
- Abstract
Staphylococcal toxic shock syndrome (TSS) is a rare but potentially life-threatening systemic bacterial intoxication. TSS is characterized by fever, hypotension, rash, digestive symptoms such as vomiting and diarrhea, multiorgan system involvement, and desquamation in the initial recovery period. We report a case of a 35-year-old woman who developed TSS caused by methicillin-resistant Staphylococcus aureus following deep inferior epigastric perforator flap breast reconstruction. Local findings are often not obvious in a case of TSS, which can make early diagnosis and appropriate initial treatment difficult. If a patient presents with characteristic symptoms of TSS after autologous breast reconstruction, TSS should be suspected and exploration of surgical wounds should be initiated as soon as possible., (Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)
- Published
- 2022
- Full Text
- View/download PDF
11. Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19.
- Author
-
Unoh Y, Uehara S, Nakahara K, Nobori H, Yamatsu Y, Yamamoto S, Maruyama Y, Taoda Y, Kasamatsu K, Suto T, Kouki K, Nakahashi A, Kawashima S, Sanaki T, Toba S, Uemura K, Mizutare T, Ando S, Sasaki M, Orba Y, Sawa H, Sato A, Sato T, Kato T, and Tachibana Y
- Subjects
- Animals, Antiviral Agents pharmacology, Antiviral Agents therapeutic use, COVID-19 Vaccines, Coronavirus 3C Proteases, Humans, Mice, Protease Inhibitors pharmacology, Protease Inhibitors therapeutic use, SARS-CoV-2, COVID-19 Drug Treatment
- Abstract
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths and threatens public health and safety. Despite the rapid global spread of COVID-19 vaccines, effective oral antiviral drugs are urgently needed. Here, we describe the discovery of S-217622 , the first oral noncovalent, nonpeptidic SARS-CoV-2 3CL protease inhibitor clinical candidate. S-217622 was discovered via virtual screening followed by biological screening of an in-house compound library, and optimization of the hit compound using a structure-based drug design strategy. S-217622 exhibited antiviral activity in vitro against current outbreaking SARS-CoV-2 variants and showed favorable pharmacokinetic profiles in vivo for once-daily oral dosing. Furthermore, S-217622 dose-dependently inhibited intrapulmonary replication of SARS-CoV-2 in mice, indicating that this novel noncovalent inhibitor could be a potential oral agent for treating COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
12. Evaluation of overall and disease-free survival in patients with free flaps for oral cancer resection.
- Author
-
Makiguchi T, Yamaguchi T, Nakamura H, Yamatsu Y, Hirai Y, Shoda K, Kurozumi S, Ibaragi S, Harimoto N, Motegi SI, Shirabe K, and Yokoo S
- Subjects
- Disease-Free Survival, Humans, Muscle, Skeletal, Prognosis, Prospective Studies, Retrospective Studies, Free Tissue Flaps, Mouth Neoplasms surgery
- Abstract
Purpose: Sarcopenia is characterized by depletion of skeletal muscle mass (SMM) and can cause increased postoperative complication in free flap procedure. One of the most important considerations while deciding the indication of the procedure is patients' survival. This study aimed to verify the relationship between low SMM and survival in patients who undergo oral cancer resection using free flap., Methods: SMM was evaluated using the skeletal muscle index (SMI cm
2 /m2 ), which was defined using cross-sectional areas of skeletal muscles on computed tomography at the level of the third lumbar vertebrae normalized for height. Overall, 111 patients who underwent primary oral cancer resection and free flaps were included. Multivariate Cox regression analyses were used to evaluate the prognostic factors for survival., Results: A total of 25 patients (22.5%) were diagnosed with low SMM. The mean SMI was 42.2 cm2 /m2 . Multivariable analyses showed that increased age (hazard ratio [HR]; 4.98, p = .004), infiltrative growth pattern INF-c (HR; 3.83, p = .037), and low SMM (HR; 2.59, p = .034) were significant negative prognostic factors for overall survival. Increased age (HR; 3.18, p = .005), extra-nodal extension (HR; 3.30, p = .001), and low SMM (HR; 2.42, p = .017) were significant negative prognostic factors for disease-free survival., Conclusions: Low SMM is a significant negative prognostic factor for overall and disease-free survival in oral cancer patients undergoing free flap. Future prospective studies are warranted to identify effective preoperative exercise and nutrition programs to improve low skeletal muscle and survival rate in patients undergoing free flap procedures., (© 2020 Wiley Periodicals LLC.)- Published
- 2020
- Full Text
- View/download PDF
13. Sacral and Rectal Necrosis after Carbon Ion Radiotherapy Reconstructed with Transpelvic Rectus Abdominis Flap.
- Author
-
Atomura D, Makiguchi T, Nakamura H, Yamatsu Y, Osone K, Motegi Y, Ogawa H, Shirabe K, and Yokoo S
- Abstract
Carbon ion radiotherapy (CIRT) has been used for malignant tumors that are difficult to excise surgically, such as sacral chordoma, and the success of its outcomes is attributable to the high dose concentration and biological effects. CIRT has produced successful clinical outcomes, and it is considered to have fewer adverse effects on surrounding normal tissues; moreover, complications have been rarely reported. We describe a 75-year-old woman with a full-thickness sacral defect, who had received CIRT for sacral chordoma 3 years earlier. Computed tomography showed sacral bone destruction, and a colonoscopy revealed rectal necrosis. Rectectomy in addition to sacral bone resection was necessary, which resulted in a huge sacral defect of slightly anxious viability. We performed reconstruction of the sacral defect by using pedicled vertical rectus abdominis myocutaneous (VRAM) flap, obliterating sacral defects and intrapelvic dead space that occurred after rectectomy. Six months after surgery, the wound had healed well, and no complication was observed. Sacral complications after CIRT may affect surrounding normal tissues such as the rectum, and it would be difficult to reconstruct the resulting complications. The vertical rectus abdominis myocutaneous flap is considered useful for the simultaneous obliteration of sacral defects and intrapelvic dead space after CIRT., Competing Interests: Disclosure: The authors have no financial interest to declare in relation to the content of this article., (Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)
- Published
- 2020
- Full Text
- View/download PDF
14. Changes in Skin Perfusion Pressure After Hyperbaric Oxygen Therapy Following Revascularization in Patients With Critical Limb Ischemia: A Preliminary Study.
- Author
-
Nakamura H, Makiguchi T, Atomura D, Yamatsu Y, Shirabe K, and Yokoo S
- Subjects
- Angiography methods, Female, Humans, Limb Salvage adverse effects, Limb Salvage methods, Lower Extremity blood supply, Male, Middle Aged, Peripheral Vascular Diseases complications, Regional Blood Flow, Treatment Outcome, Wound Healing physiology, Endovascular Procedures adverse effects, Endovascular Procedures methods, Hyperbaric Oxygenation methods, Ischemia etiology, Ischemia surgery, Perfusion Imaging methods, Skin blood supply, Tibial Arteries diagnostic imaging, Tibial Arteries surgery
- Abstract
Hyperbaric oxygen (HBO) therapy promotes wound healing in patients with ischemic disease; however, HBO-induced changes in skin peripheral circulation have not been evaluated in clinical practice. Here, we investigated these changes in patients with critical limb ischemia (CLI), with a focus on the angiosome of crural blood vessels with blood flow improved by endovascular therapy (EVT). Six patients with CLI and ulcers who were treated with HBO after EVT (7 limbs; 1 patient had ulcers in the bilateral limbs) and 3 healthy subjects (6 limbs) were enrolled. HBO therapy was performed at 2 atm under 100% oxygen for 90 min per session. Skin perfusion pressure (SPP) was measured in the dorsum and sole of the foot 1 hour before (pre-SPP) and after (post-SPP) HBO therapy. ΔSPP was calculated as post-SPP minus pre-SPP. SPP measurement regions were divided into those that did (direct region) and did not (indirect region) correspond to the vascular angiosome in which angiography findings of the crus were improved after EVT; i.e., when the anterior tibial artery was effectively treated with EVT, the dorsum was the direct region and the sole was the indirect region, and vice versa when the posterior tibial artery was treated. In the direct, indirect, and healthy subject groups, the ΔSPPs were 20.5±8.7 (p=0.002), -6.4±10.9, and -15.1±18.1 (p=0.014), respectively; that of the direct group was significantly greater than that of the other groups. These results suggest that short-term improvement of the peripheral circulation by HBO therapy was significant in patients with successful revascularization.
- Published
- 2020
- Full Text
- View/download PDF
15. Fibro-osseous Pseudotumor of the Toe.
- Author
-
Atomura D, Makiguchi T, Yamaguchi T, Nakamura H, Yamatsu Y, Shirabe K, and Yokoo S
- Published
- 2020
16. Open Laparoscopic-assisted Repair of Abdominal Wall Hernia and Bulge.
- Author
-
Nakamura H, Makiguchi T, Atomura D, Yamatsu Y, Katoh R, Ogawa H, Shirabe K, and Yokoo S
- Abstract
Rectus abdominalis musculocutaneous (RAM) flaps have numerous uses in the treatment of large defects. However, flap harvesting can result in abdominal wall incisional hernia and bulge, which are challenging problems. Most of these problems occur below the arcuate line abdominal wall. However, there will be differences that are unique to each patient in the area of hernia or bulge. The open approach repair appears to be used most often, but the precise area of hernia and bulge is often not distinguished. This report describes a case that was treated using a new repair method, which had the clear advantage of allowing the precise area of abdominal wall weakness to be recognized. A 53-year-old man underwent left vertical RAM flap for reconstruction after tongue carcinoma resection. Six months after the operation, lower abdominal wall hernia and bulge were observed. Open laparoscopic-assisted repair was performed. Pneumoperitoneum led to distension of the abdominal cavity and outward stretching of the abdominal wall, so that the area of hernia and bulge protruded to a great degree. In this phase, by making the operating room slightly dark, the area became more clearly recognizable. When direct plication of the hernia and bulging area was required, the contralateral component separation technique was performed. This study describes an inventive repair procedure for abdominal wall hernia or bulge after RAM flap, with the combined advantages of open and laparoscopic repair., Competing Interests: Disclosure: The authors have no financial interest to declare in relation to the content of this article., (Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)
- Published
- 2019
- Full Text
- View/download PDF
17. Hyperthermia in the treatment of recurrent abdominal desmoid tumor.
- Author
-
Ishikawa H, Hirakawa H, Takahashi K, Kawashima Y, Yoshida T, Isobe T, Matono S, Kawahara R, Hisaka T, Horiuchi H, Nakayama M, Okabe Y, Yamatsu Y, Yano H, and Akagi Y
- Subjects
- Humans, Hyperthermia, Induced, Male, Recurrence, Tomography, X-Ray Computed, Abdominal Neoplasms therapy, Fibromatosis, Aggressive therapy
- Abstract
The most suitable management of recurrent abdominal desmoid tumor is still unclear. A case of recurrent huge abdominal desmoid tumor successfully treated by hyperthermia therapy is described. A 63-year-old man was operated upon for desmoid tumor in the retroperitoneum involving pancreas, posterior wall of the stomach and transverse mesocolon in 2007. In 2008, the tumor recurred and could not be resected because of the patient refused the operation. Several therapies using tamoxifen, anastrozole, imatinib mesylate and radiotherapy were all ineffective. The tumor grew bigger and bigger during a treatment period. Finally, hyperthermia treatment was applied to the tumor. The size of the recurrent desmoid tumor reduced 75% by hyperthermia treatment for 46-month. Base on this experience, we recommend hyperthermia as the treatment for patients with recurrent abdominal desmoid tumor that several therapeutic strategies did not achieve a remarkable response.
- Published
- 2014
18. Accessory carotid body within the parathyroid gland III of the chicken.
- Author
-
Yamatsu Y and Kameda Y
- Subjects
- Animals, Female, Immunohistochemistry, Male, Microscopy, Electron, Parathyroid Glands innervation, Carotid Body chemistry, Carotid Body cytology, Chickens anatomy & histology, Parathyroid Glands chemistry, Parathyroid Glands cytology
- Abstract
In the chicken, the cranial and caudal parathyroid glands (parathyroid gland III and IV), which are connected to each other, are located adjacent to the carotid body. In the present study, we found that a mass of glomus cells surrounded by a thick layer of connective tissue was frequently distributed within the parathyroid gland III. The glomus cells in the parathyroid III, as well as those of the carotid body, expressed intense immunoreactivity for serotonin, chromogranin A, and tyrosine hydroxylase but no immunoreactivity for neuropeptide Y. The cells possessed long cytoplasmic processes containing dense-cored vesicles of 70-220 nm in diameter, and were in close association with sustentacular cells. In and around the glomus cell clusters of the parathyroid III, dense networks of varicose fibers showed immunostaining with the monoclonal antibody TuJ1 to a neuron-specific class III beta-tubulin isotype, c beta 4. Furthermore, the distribution was also detected of numerous galanin-, vasoactive intestinal peptide (VIP)-, substance P-, and calcitonin gene-related peptide (CGRP)-immunoreactive fibers.
- Published
- 1995
- Full Text
- View/download PDF
19. Glomus cell differentiation in the carotid body region of chick embryos studied by neuron-specific class III beta-tubulin isotype and Leu-7 monoclonal antibodies.
- Author
-
Kameda Y, Yamatsu Y, Kameya T, and Frankfurter A
- Subjects
- Animals, Antibodies, Monoclonal, CD57 Antigens, Carotid Body cytology, Cell Differentiation physiology, Cell Movement physiology, Female, Immunohistochemistry, Male, Microscopy, Immunoelectron, Antigens, CD immunology, Antigens, Differentiation, T-Lymphocyte immunology, Carotid Body embryology, Chick Embryo cytology, Ganglia, Autonomic cytology, Neurons immunology, Tubulin immunology
- Abstract
Development of the carotid body and the glomus cell groups in the wall of the common carotid artery and its branches was examined in chickens at various developmental stages by immunohistochemistry using three different monoclonal antibodies, i.e., anti-neuron-specific class III beta-tubulin isotype (TuJ1), anti-rat brain beta-tubulin, and anti-Leu-7 (HNK-1) antibodies. All the antibodies reacted with neurons. The carotid body anlage was first discerned at 6 days of incubation at the lateral portion of the third branchial artery. The cells and nerve fibers immunoreactive for TuJ1, brain beta-tubulin and Leu-7, which were connected with the distal ganglion of the vagus nerve, were found around the carotid body anlage at this stage. Within the carotid body anlage, no immunoreactivity yet appeared. The immunoreactive cells were accumulated around the carotid body anlage until 8 days of incubation. From 9 days of incubation, the immunoreactive cells continuing with the distal vagal ganglion began to enter into the carotid body anlage and also dispersed widely along the common carotid artery and its branches, giving rise to the glomus cells. At 12 days of incubation, a large portion of the carotid body was occupied by the immunoreactive cells. Thus, the present study evidences that the glomus cells in the carotid body and around the arteries are emigrés that arrive in each residential place from the distal vagal ganglion. Immunoreactivity for TuJ1, brain beta-tubulin, and Leu-7 in the glomus cells started to decrease at late stages of embryonic development. After hatching, no TuJ1-immunoreactive cells were detected in the carotid body region.
- Published
- 1994
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.